The Official Publication of ITACCS - International Trauma ...
The Official Publication of ITACCS - International Trauma ...
The Official Publication of ITACCS - International Trauma ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
• HEXTEND (6% Hetastarch in Lactated Electrolyte injection) is indicated in the treatment <strong>of</strong> hypovolemia<br />
when plasma volume expansion is desired. It is not a substitute for blood or plasma.<br />
• Solutions containing hetastarch are contraindicated in patients with known sensitivity to hydroxyethyl<br />
starch, bleeding disorders or with congestive heart failure where volume overload is a potential problem.<br />
• Solutions containing hetastarch should not be used in renal disease with oliguria or anuria not related<br />
to hypovolemia.<br />
Please see brief summary <strong>of</strong> Prescribing Information on following page.
Change language